676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)

BACKGROUND: Interest in patient health experience as part of a benefit–risk assessment for new drug approvals is increasing. Patient-centeredness, a key metric in the 2010 Affordable Care Act, is also a growing area of focus in healthcare. LEF, a new antibiotic in development for treating adults wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas, Colman, Sam, Alexander, Elizabeth, Stein, Daniel, Fitts, David, Goldberg, Lisa, Schranz, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811025/
http://dx.doi.org/10.1093/ofid/ofz360.744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811025/
http://dx.doi.org/10.1093/ofid/ofz360.744

Ejemplares similares